Digital Supportive Care Awareness & Navigation
NCT03628794 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2019-07-18
Summary
To pilot test the feasibility, usability, and preliminary efficacy of the D-SCAN mobile application in cancer patients and caregivers at Duke.
Conditions
- Supportive Care
Interventions
- DEVICE
-
D-SCAN
Subjects will receive a digital patient navigator service in the form of a mobile application ("app"), which has been designed at Duke, with feedback from Duke Cancer Institute (DCI) patients, caregivers and clinicians. Its purpose is to facilitate awareness of available Cancer Patient Support Program (CPSP) services at Duke, and to also help patients recognize their unmet symptom management needs. Subjects receiving the D-SCAN mobile app will also complete a survey every week within the app. The first 15 patients and 5 caregivers randomized into the intervention arm (those receiving the app) will also be asked to participate in a qualitative interview assessment at week 12, +/- 3 weeks
Sponsors & Collaborators
- collaborator INDUSTRY
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-25
- Primary Completion
- 2019-03-01
- Completion
- 2019-03-01
Countries
- United States
Study Locations
More Related Trials
-
Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
NCT00176540 ·Status: TERMINATED ·Phase: NA
-
Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel
NCT00215748 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Usability of PointCheck
NCT04448314 ·Status: COMPLETED
-
Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation
NCT02248779 ·Status: COMPLETED
-
Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab
NCT03653052 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
NCT02792465 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Smartphone App for Cancer Medication Adherence
NCT05225090 ·Status: COMPLETED ·Phase: NA
-
Statin Therapy in Young Adult Survivors of Childhood Cancer
NCT01733953 ·Status: COMPLETED ·Phase: PHASE2
-
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
NCT01832402 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenomic Testing to Personalize Supportive Oncology
NCT04500301 ·Status: COMPLETED ·Phase: NA
-
Software Monitoring of Treatment Related Toxicities in Advanced Renal Cell Carcinoma
NCT03229083 ·Status: COMPLETED ·Phase: NA
-
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
NCT01856114 ·Status: COMPLETED ·Phase: PHASE2
-
Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer
NCT01673711 ·Status: COMPLETED
-
Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
NCT01769768 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients
NCT00728468 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Pharmacokinetic Study of TAK-285 in Patients With Advanced Cancer
NCT00535522 ·Status: COMPLETED ·Phase: PHASE1
-
Fostering Oral Chemotherapy Understanding and Safety (FOCUS) Study
NCT06952790 ·Status: RECRUITING ·Phase: NA
-
FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT00769288 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation
NCT03143894 ·Status: TERMINATED ·Phase: NA
-
Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke
NCT00005883 ·Status: COMPLETED ·Phase: PHASE1
-
Acetylamantadine Excretion by Cancer Patients
NCT02277938 ·Status: UNKNOWN
-
Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2
NCT04142463 ·Status: UNKNOWN ·Phase: NA
-
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
NCT01497925 ·Status: COMPLETED ·Phase: PHASE1
-
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer
NCT02410382 ·Status: TERMINATED ·Phase: PHASE2
-
Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery
NCT04029857 ·Status: WITHDRAWN ·Phase: PHASE3